The olfactory test established by Henkin: is it reliable and does it correlate to established psychophysical tests?

Eur Arch Otorhinolaryngol

Smell and Taste Clinic, Department of Otorhinolaryngology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

Published: October 2024

Purpose: This pilot study aimed to determine whether the Henkin olfactory test discriminates between the olfactory function of patients with olfactory loss and healthy individuals, and whether the Henkin test is correlated with a validated psychophysical olfactory test.

Methods: Participants underwent olfactory testing using the modified Henkin test (including detection [DT] and recognition [RT] thresholds, magnitude estimation [ME], and hedonic ratings [H], for four different odors) and the extended "Sniffin' Sticks" test battery (odor detection, discrimination, identification).

Results: Forty-four individuals (28 women, aged 19-81 years, mean: 39 years) were included. Twenty-three were healthy (mean age: 38 years) and 21 had olfactory dysfunction (OD) (mean age: 40 years). OD patients had worse mean DT, lower composite RT, and lower ME ratings. Mean and individual odor H ratings were not significantly different between the groups. Most individuals were classified as hyposmic when using the prescribed classification by Henkin, with only very few satisfying the stringent criteria of anosmia and normosmia. Modified Henkin subtests were all positively correlated with each other and with the "Sniffin' Sticks", except for Unpleasant Mean H which was only correlated with Pleasant Mean H; and Pleasant mean H which was not correlated with mean DT scores.

Conclusion: The Henkin test is able to separate between OD patients and controls. However, modifications to the conduct of this test may be required. Studies that used this test should be carefully interpreted.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11416371PMC
http://dx.doi.org/10.1007/s00405-024-08900-wDOI Listing

Publication Analysis

Top Keywords

henkin test
12
olfactory test
8
modified henkin
8
"sniffin' sticks"
8
age years
8
olfactory
7
henkin
7
test
7
test established
4
established henkin
4

Similar Publications

The olfactory test established by Henkin: is it reliable and does it correlate to established psychophysical tests?

Eur Arch Otorhinolaryngol

October 2024

Smell and Taste Clinic, Department of Otorhinolaryngology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

Purpose: This pilot study aimed to determine whether the Henkin olfactory test discriminates between the olfactory function of patients with olfactory loss and healthy individuals, and whether the Henkin test is correlated with a validated psychophysical olfactory test.

Methods: Participants underwent olfactory testing using the modified Henkin test (including detection [DT] and recognition [RT] thresholds, magnitude estimation [ME], and hedonic ratings [H], for four different odors) and the extended "Sniffin' Sticks" test battery (odor detection, discrimination, identification).

Results: Forty-four individuals (28 women, aged 19-81 years, mean: 39 years) were included.

View Article and Find Full Text PDF

Background: There is wide variation in stress test utilization before major vascular surgery and adherence to practice guidelines is unclear. We defined rates of stress test compliance at our institution and led a quality improvement initiative to improve compliance with American Heart Association (ACC/AHA) guidelines.

Methods: We implemented a stress testing order set in the electronic medical record at one tertiary hospital.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined whether reducing the dose of apixaban from 5 mg to 2.5 mg twice daily is safe for patients with cancer-associated venous thromboembolism (VTE) who have already undergone 6-12 months of anticoagulation therapy.
  • In a trial involving 360 cancer patients, the incidence of major and clinically relevant nonmajor bleeding was similar between the 2.5 mg and 5 mg groups, with rates of 8.9% and 12.2%, respectively.
  • The findings suggest that reducing the dose of apixaban does not significantly affect bleeding risks, recurrent VTE, or mortality rates in cancer patients, indicating that the
View Article and Find Full Text PDF

PEDF-derived peptide protects against Amyloid-β toxicity in vitro and prevents retinal dysfunction in rats.

Exp Eye Res

May 2024

Clinical Research Institute, Rambam Health Care Campus, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel; Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel. Electronic address:

Amyloid-beta (Aβ), a family of aggregation-prone and neurotoxic peptides, has been implicated in the pathophysiology of age-related macular degeneration (AMD). We have previously shown that oligomeric and fibrillar species of Aβ42 exerted retinal toxicity in rats, but while the consequences of exposure to amyloid were related to intracellular effects, the mechanism of Aβ42 internalization in the retina is not well characterized. In the brain, the 67 kDa laminin receptor (67LR) participates in Aβ-related neuronal cell death.

View Article and Find Full Text PDF

Aim: To analyze the results of screening of the population older than 40 years for early detection of risk factors for cardiovascular diseases in real clinical practice of family clinics in the Aral Sea region.

Material And Methods: The results of screening of the population older than 40 years were analyzed for a total of 2,430 respondents from family clinics of the district (Republic of Uzbekistan, Republic of Karakalpakstan, Ellikkala district) according to the modified WHO PEN protocol. 1,020 of the respondents with blood pressure ≥140/90 mm Hg were included in the study (mean age, 57.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!